Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business - ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business - ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects

Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital. Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company. Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India. KEC: got orders worth Rs 1,002 cr for civil and defence residential projects

Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company.

Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India.

KEC: got orders worth Rs 1,002 cr for civil and defence residential projects Tata Motors: board has approved to set up a wholly-owned subsidiary for its commercial vehicles business – ‘TML Commercial Vehicles’. The company also approved the merger of Tata Motors Finance with Tata Capital.

Kotak Mahindra Bank: received RBI approval to sell a 70% stake in its general insurance subsidiary to Zurich Insurance Company.

Torrent Pharma: signed an agreement with the Japanese pharma company ‘Takeda’ to market its acid reflux drug in India.

KEC: got orders worth Rs 1,002 cr for civil and defence residential projects

Please follow and like us:

By earn

You Missed

Understanding Nifty’s Historical Drops Below the 200 EMA

Strategic Steps to Buy Chola Fin Nov Fut: A 10-Day Plan

Market Wrap: Nifty Corrects Over 200 Points but Closes in Green

The Historic Growth of the BlackRock IBIT ETF: A 38% Surge